MarketInOut Stock Screener Log In | Sign Up

Sanofi India Ltd

Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 15:51
Sanofi India Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
Market Capitalization64,025 mln
Float8.48 mln
Earnings Date10/29/2026

EPS

141
Exceptional

P / E

21.28
Premium valuation

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.19
Reliable

Relative Strength

85 / 100
Strongly outperforming

Debt / Equity

0.02
Debt-free

Business Description

Sanofi India Limited is a Mumbai-based pharmaceutical company that develops and sells medicines across a wide range of health conditions, including diabetes, heart disease, infections, and pain management. Operating under well-known brands such as Lantus, Clexane, Combiflam, Allegra, and Enterogermina, the company distributes its products throughout India and exports to around 24 countries worldwide. Founded in 1956 and formerly known as Aventis Pharma Limited, it operates as a subsidiary of Hoechst GmbH.

Key Fundamentals

EPS141
P/E21.28
ROE41.21
RPS784
ROIC48.97
ROA24.68
Interest Cover282
EBITDA, mln4,736
EV / EBITDA14.19
EV / EBIT15.37
Revenue, mln18,052
EV / Revenue3.72

Quote Details

Last 2,992.00
Change -83 (-2.7%)
Open 3,080.00
Volume 13,820
Turnover 41,349,440
Average Volume 15,239

Financial Ratios

Pre-Tax Profit Margin24
Leverage Ratio1.70
Current Ratio1.69
Price / Book8.52
Price / Tangible Book8.53
Price / Cash Flow44.00
Price / Free Cash Flow16.55
Debt / Equity0.02
Price / Sales3.90

Financial Strength

Altman Z-Score9.94
Piotroski F-Score 6 / 9
Beneish M-Score-3.19
Price to Intrinsic Value1.42
Price to Graham Number2.77
Shiller PE Ratio11.75

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.83% 92 / 100   
1 Month -4.72% 64 / 100   
2 Months -11.57% 39 / 100   
6 Months -12.8% 39 / 100   
1 Year -34.11% 25 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog